Key result
The baseline prevalence of hypertension among Jordanian patients with type 2 diabetes was 74.6% (95% CI: 72.2-76.9%), with a one-year incidence of 26.2% among those initially free of hypertension.
Why the study?
Assessing the prevalence and progression of hypertension among diabetics is crucial for designing strategies to manage hypertension and its life-threatening complications.
Cross-Sectional (n=1,382)
There is a high prevalence (74.6%) and one-year incidence (26.2%) of hypertension among Jordanian patients with type 2 diabetes, with older age and family history being significant risk factors for uncontrolled hypertension.
Highlights need for hypertension vigilance among Jordanian T2DM patients; leaves open prospective evaluation of progression and determinants.
No takes yet. Share an insight, caveat, or question.
Salameh et al. (2021) conducted a cross-sectional in Type 2 diabetes mellitus (n=1,382). Type 2 diabetes mellitus was evaluated on Prevalence of hypertension at baseline (95% CI 72.2-76.9). The baseline prevalence of hypertension among Jordanian patients with type 2 diabetes was 74.6% (95% CI: 72.2-76.9%), with a one-year incidence of 26.2% among those initially free of hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: